# Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Study · id `cardio:ct-nct02618577` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02618577](<https://clinicaltrials.gov/study/NCT02618577>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02618577

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2608 participants.

## Technical summary

Registry record NCT02618577. Randomized; double masking; primary purpose prevention. Start 2016-02 (actual); primary completion 2022-12-31 (actual). Results posted on 2025-02-06.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 2608 participants (enrolled count; ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Started: 2016-02 (actual) (ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Results first posted: 2025-02-06 (ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Bulgaria; Czechia; Denmark; France; Germany; Greece; Hungary; Italy; Netherlands; Poland; Portugal; Romania; Spain; Sweden; Ukraine; United Kingdom (ClinicalTrials.gov record NCT02618577, source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02618577-2025-02-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
- Acronym: NOAH
- Condition: Atrial High Rate Episodes
- Intervention (Drug): Edoxaban
- Intervention (Drug): ASA
- Lead sponsor: Atrial Fibrillation Network
- Lead sponsor class: OTHER
- Collaborator: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Collaborator class: INDUSTRY
- Collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Edoxaban (`cardio:edoxaban`)
- Registry lists this organization as the lead sponsor: Atrial Fibrillation Network (`cardio:org-atrial-fibrillation-network`)
- Registry lists this organization as a collaborator: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (`cardio:org-daiichi-sankyo-europe-gmbh-a-daiichi-sankyo-company`)
- Registry lists this organization as a collaborator: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) (`cardio:org-deutsches-zentrum-fur-herz-kreislauf-forschung-dzhk`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes (`cardio:pubmed-37622677`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 33469252e9b1150d54fe0b16bbecda7d627ab11c9cba9fabf7638655f1a33bb5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
